|
|
Progress in Asia Helps Myeloma Patients Everywhere
In this week’s blog, IMF Chairman of the Board and Chief Scientific Officer Dr. Brian G.M. Durie discusses exciting key takeaways and learnings from the recently concluded 7th Annual Asian Myeloma Network (AMN) Summit in Bangkok, Thailand, and how all these initiatives and projects will make a lasting global impact for myeloma patients around the world. He is happy to report that wonderful benefits came out of the 3rd Doctor Masterclass Program, the 3rd Patient Forum, and the 7th Scientific Summit which focused on networking with myeloma experts from around Asia. Dr. Durie does a comprehensive summary of the following: Dr. Bruno Paiva’s keynote lecture; topics discussed during the Open Session; Working Group Reports; the current status of AMN Clinical Trials and New Research Projects; as well as the first-ever AMN awards ceremony, where Dr. Kazuyuki Shimizu— hemato-oncologist, long-time IMWG member, and former staff physician at Higashi Nagoya National Hospital— became the first recipient of the AMN Distinguished Service Award. As aptly put by Dr. Durie, the rest of the world will be watching and waiting to see if these projects get going and to find out when results will emerge.
|
|
|
|
|
|
|
‘Dean of Asian Myeloma’ Dr. Kazuyuki Shimizu to Receive First Asian Myeloma Network (AMN) Distinguished Service Award
The International Myeloma Foundation (IMF) held its first-ever Asian Myeloma Network (AMN) awards ceremony this year, during the 7th Annual AMN Summit in the Shangri-La Hotel in Bangkok, Thailand, from October 20-22, 2023. The Asian Myeloma Network Distinguished Service Award was conceived to recognize and honor the lifelong achievements of deserving AMN myeloma specialists, who have made a considerable impact in the field of myeloma research, clinical trials, and patient support. This year, the first-ever AMN Distinguished Service Awardee is Dr. Kazuyuki Shimizu—a hemato-oncologist; a member of the International Myeloma Working Group (IMWG) since 2000; and a former staff physician at Higashi Nagoya National Hospital.
|
|
|
|
|
|
|
Listen to IMF President and CEO Yelak Biru Share His Myeloma Story
On this episode of “Transforming Biopharma,” Managing Partner of ZS Associates Maria Whitman talks with International Myeloma Foundation (IMF) President and CEO Yelak Biru on how he merged his 25 years of data analytic expertise at Fortune 500 companies with his 28 years of living with the complex blood cancer multiple myeloma into a service-oriented mindset. Listen as Yelak shares that he is “not an advocate, but someone who is part of a relay race and I'm just carrying the baton from the person that came before me and I'm going to respectfully carry it forward and give it to the person that's going to come after me.” In his effort to pass this baton, Yelak leans on data, technology, and AI to envision a future where all patients are met exactly where they are in their disease journeys.
|
|
|
|
|
|
|
Register Now for the November 2nd IMF Patient and Family Webinar
Register now for the upcoming IMF Patient and Family Webinar on Thursday, November 2, at 2:30 p.m. PT | 3:30 p.m. MT | 4:30 p.m. CT | 5:30 p.m. ET. IMF Chairman of the Board and Chief Scientific Officer Dr. Brian G.M. Durie will present Myeloma 101. IMF Nurse Leadership Board Member Mary Steinbach, DNP, DPRN, will cover managing side effects and complications of myeloma care. Dr. Rafat Abonour will focus on frontline treatment options. Finally, Dr. Ajai Chari will shed light on relapse and new immune therapies. At the end of each presentation, participants will have time to ask questions.
|
|
|
|
|
|
|
Register Now for the November 4th M-Power Community Workshop in Detroit
At this M-Power Community Workshop, myeloma experts will discuss health empowerment and multiple myeloma awareness in the African American community. Check-in begins at 9:30 a.m. EST at Tabernacle Missionary Baptist Church (2080 W Grand Blvd) in Detroit. The workshop will take place from 10:00 a.m. to 12:30 p.m. EST, with refreshments provided.
|
|
|
|
|
|
|
Donate Your Vehicle This Fall
We’re participating in Cartober—a national campaign that raises awareness around this powerful means of giving. You, too, can participate by donating your vehicle to the IMF! The process is easy and free, and we’ll use the proceeds to fund our research, education, and support programs for the myeloma community. Bonus: We will provide you with the proper tax-deduction paperwork.
|
|
|
|
|
|
|
Medicare Open Enrollment Period Now Active
Medicare's Open Enrollment Period is October 15 - December 7. This timeframe is your chance to explore Medicare Plans and see what works for you. Plans can change from year to year, and your health needs may change, too. The International Myeloma Foundation and our InfoLine team do not have recommendations about Medicare. We do, however, encourage you to explore Medicare.gov, or contact your local State Health Insurance Assistance Program (SHIP) to get the phone number for Medicare assistance for your state.
|
|
|
|
|
|
|
Disparities in Myeloma Made Simple!
In this episode "Myeloma Made Simple,” IMF Chief Medical Officer Dr. Joseph Mikhael explores the inequities in healthcare faced by underserved populations, particularly African American patients with multiple myeloma. Discover the factors contributing to these disparities and learn about the International Myeloma Foundation's commitment to improving outcomes through the M-Power Project.
|
|
|
|
|
|
|
#ASKDRDURIE | Dr. Durie's Weekly Web Video Series
What is the IMF's Asian Myeloma Network?
|
|
|
|
|
|
Instagram @IMFmyeloma